02 / CENTRAL APPETITE REGULATION
Brain signalling
Helps regulate hunger and satiety, reducing appetite and food intake.
Madrid · Ingredient guide
Tirzepatide treatmentin Moncloa-Aravaca
TirzepatideDual GIP / GLP-1 receptor agonistThe active ingredient in Mounjaro
- Understand tirzepatide and Mounjaro
- Dual GIP and GLP-1 action explained
- English-speaking review and continuing support
- Local pharmacy collection if treatment is prescribed
English-speakingMedical assessment
Telephone or videoPrivate appointment
Prescription by emailWhen appropriate
Local pharmacyCheck stock directly
Medical Director
Dr Ben Harry Clegg
Málaga registration 292911940 · Nerja Medical Center NICA 55712
A clear explanation of the medicine behind Mounjaro.
The ingredient behind Mounjaro
This page answers ingredient-level questions. For the branded pen, appointment process and continuing care, the Mounjaro guide remains the main treatment reference.
GIP + GLP-1
Two receptors
Tirzepatide acts at both GIP and GLP-1 receptors. It is a different medicine from the GLP-1 receptor agonist semaglutide.
Read the relevant guideWeight and diabetes
Two clinical contexts
Mounjaro has authorised uses in type 2 diabetes and adult weight management; assessment follows the relevant indication.
Read the relevant guideReview, then follow-up
One individual plan
Your prescription, response, tolerability and monitoring inform the next step. Do not increase treatment on your own.
Read the relevant guideClinical references: EMA: Mounjaro · EMA: Mounjaro product information
Mechanism of actionTwo receptor targets.
Two receptor targets.
One treatment molecule.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It activates receptors involved in glucose regulation and appetite control.
03 / GLUCOSE REGULATION
Pancreatic response
Supports glucose-dependent insulin release. Treatment effects and safety still require individual review.
Simplified educational model; not all receptor locations or effects are shown.EMA: Mounjaro mechanism of action ↗
The distinctions that matter
What the doctor will clarify
Swipe across to read the comparison →| Your question | The clinical distinction |
|---|---|
| Is it another name for Mounjaro? | Mounjaro is a brand; tirzepatide is its active ingredient. |
| Who may qualify for weight management? | Adult BMI ≥30, or BMI ≥27 and <30 with a weight-related condition, is the starting indication check—not automatic approval. |
| Is it equivalent to a semaglutide dose? | No direct milligram-for-milligram substitution is made. |
| How is progress assessed? | A review considers treatment response, side effects, nutrition and relevant medical monitoring. |
A clear medical process
From your first question to a clear plan
Start with a review
Book the relevant medical assessment; the optional pre-check is not a prescription decision.
Talk to the doctor
Discuss your history, medicines and the evidence needed to make a safe plan.
Agree the next step
Receive advice, any onward-care recommendation and an e-prescription only if appropriate.
Collect and follow up
Use a participating pharmacy and follow the agreed review plan. Medicine cost is separate.
Have these details ready
- Current medicine, strength and last injection date
- Height, current weight and weight-related diagnoses
- Other prescriptions and relevant test results
- Any previous GLP-1 treatment and why it changed
Know what happens next
- Separate ingredient questions from branded-product instructions
- Understand the indication and evidence needed
- Leave with a monitoring and follow-up plan if treatment is suitable
Genuine local guidance
Tirzepatide care around Moncloa-Aravaca
For tirzepatide care in Moncloa-Aravaca, bring the name and strength of the Mounjaro pen, the date of the last injection and any recent treatment record. A change of dose or product needs a clinician-led plan. Moncloa-Aravaca is in the Madrid area. For a pharmacy search, use “Madrid” and then narrow the results to your street or postcode in Moncloa-Aravaca. Other covered places in the surrounding region include Chamberí, Madrid Centro, Madrid, Tetuán. The official Madrid resource below is for finding pharmacy and duty-service information, not a live medicine-stock feed. Contact the pharmacy with the exact prescribed brand and strength before travelling.
Appointments are provided remotely. Our physical clinic is in Nerja; this page does not claim a Moncloa-Aravaca branch. Local examination or tests may be recommended when needed.
Place-name reference: GeoNames (CC BY 4.0). Local directories may use the municipality name. This page describes online coverage, not a clinic branch.
Before your review
Questions in Moncloa-Aravaca
Is tirzepatide a GLP-1 medicine?
It acts at both GIP and GLP-1 receptors, which is why it is described as a dual agonist.
Is this different from the Mounjaro city page?
This guide explains the ingredient and its clinical context. The Mounjaro page covers the branded treatment pathway and pen-specific guidance.
Does meeting the BMI threshold guarantee treatment?
No. The doctor also checks medical history, safety, medicines and whether the proposed treatment is appropriate.
Can I switch from Wegovy?
A doctor can assess a switch. Do not overlap or convert doses yourself; see the dedicated switching guide.
Can I arrange follow-up while visiting Moncloa-Aravaca?
Yes, you can request a review during your stay. Bring the treatment record and allow time for any additional checks.
Does a prescription guarantee local supply?
No. The pharmacy controls stock and dispensing; check the exact strength before making a journey.
Find a pharmacy in Moncloa-Aravaca+
Use the official Madrid pharmacy resource and search for “Moncloa-Aravaca” or the municipality “Madrid”. It provides pharmacy and duty-service information, not live medicine stock.
Open the official Madrid pharmacy resource ↗National guidance and nearby locations+
Continue with the national guide, another treatment guide for Moncloa-Aravaca, or a published nearby location.
Safety first
Do not combine or change injectable treatments without a medical plan. Severe persistent abdominal pain or repeated vomiting needs urgent assessment; call 112 for a life-threatening emergency.
Official sources